Clinical Data Inc

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 2 pages Amendment No. 1, Dated as of April 4, 2011 (This “Amendment”), to the Merger Agreement Referred to Below, Among Fl Holding CV, an Entity Organized Under the Laws of the Netherlands (“Parent”), Magnolia Acquisition Corp., a Delaware Corporation and an Indirect Wholly Owned Subsidiary of Parent (“Purchaser”), Forest Laboratories, Inc., a Delaware Corporation and the Indirect Parent of Parent (The “Guarantor”) and Clinical Data, Inc., a Delaware Corporation (The “Company”)
12/34/56
EX-2.1
from DEFA14A 2 pages Amendment No. 1, Dated as of April 4, 2011 (This “Amendment”), to the Merger Agreement Referred to Below, Among Fl Holding CV, an Entity Organized Under the Laws of the Netherlands (“Parent”), Magnolia Acquisition Corp., a Delaware Corporation and an Indirect Wholly Owned Subsidiary of Parent (“Purchaser”), Forest Laboratories, Inc., a Delaware Corporation and the Indirect Parent of Parent (The “Guarantor”) and Clinical Data, Inc., a Delaware Corporation (The “Company”)
12/34/56
EX-2.3
from 8-K 19 pages [Form Of] Contingent Value Rights Agreement
12/34/56
EX-2.3
from DEFA14A 19 pages [Form Of] Contingent Value Rights Agreement
12/34/56
EX-2.2
from 8-K 38 pages Securityholder Tender and Support Agreement
12/34/56
EX-2.2
from DEFA14A 38 pages Securityholder Tender and Support Agreement
12/34/56
EX-2.1
from 8-K 90 pages Agreement and Plan of Merger Among Fl Holding CV, Magnolia Acquisition Corp., Forest Laboratories, Inc. and Clinical Data, Inc. Dated as of February 22, 2011
12/34/56
EX-2.1
from DEFA14A 90 pages Agreement and Plan of Merger Among Fl Holding CV, Magnolia Acquisition Corp., Forest Laboratories, Inc. and Clinical Data, Inc. Dated as of February 22, 2011
12/34/56
EX-2.1
from 8-K 3 pages Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted and Filed Separately With the Securities and Exchange Commission Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as Amended. Amendment to Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K 93 pages Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K 37 pages Asset Purchase Agreement by and Among Avalon Pharmaceuticals, Inc., as “Seller”, Clinical Data, Inc., as “Seller Parent”, Pgxhealth, LLC, as “Seller Affiliate” and Intrexon Corporation as “Buyer”
12/34/56
EX-2.1
from 425 76 pages Stock Purchase Agreement by and Among Clinical Data, Inc., a Delaware Corporation, Clinical Data B.V., a Company Registered Under the Laws of the Netherlands, Beckman Coulter, Inc., a Delaware Corporation Beckman Coulter Gmbh, a Company Registered Under the Laws of the Republic of Germany Beckman Coulter Holdings Gmbh a Company Registered Under the Laws of the Republic of Germany Dated as of April 1, 2009
12/34/56
EX-2.1
from 8-K/A 76 pages Stock Purchase Agreement by and Among Clinical Data, Inc., a Delaware Corporation, Clinical Data B.V., a Company Registered Under the Laws of the Netherlands, Beckman Coulter, Inc., a Delaware Corporation Beckman Coulter Gmbh, a Company Registered Under the Laws of the Republic of Germany Beckman Coulter Holdings Gmbh a Company Registered Under the Laws of the Republic of Germany Dated as of April 1, 2009
12/34/56
EX-2.2
from S-4/A 3 pages First Amendment to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.1
from 8-K 72 pages Agreement and Plan of Merger by and Among Clinical Data, Inc., Irides Acquisition Corp. and Icoria, Inc. Dated as of September 19, 2005
12/34/56
EX-2.1
from 8-K ~10 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K >50 pages Agreement and Plan of Merger
12/34/56
EX-2
from 8-K ~5 pages Amendment Dated as of April 29, 2003 to Asset Purchase Agreement Dated as of December 9, 2002 (As Amended) by and Among Elan Pharmaceuticals, Inc., Elan Diagnostics, Inc., Novitron International, Inc. and Clinical Data Inc. Amendment
12/34/56
EX-2
from 8-K 1 page Re: Asset Purchase Agreement
12/34/56
EX-2
from 8-K 1 page Re: Starrsed/Diesse Amendment
12/34/56